Researchers from the Spanish National Cancer Research Centre (Madrid, Spain) have published findings suggesting that patients with Alzheimer’s disease (AD) have a higher risk of developing glioblastoma and a lower risk of lung cancer. The data were published in Scientific Reports, and could pave the way for researchers to discover new uses for existing drugs, as well as novel therapeutic combinations, to treat patients based on their specific genomic information.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.